FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.
Thompson Names Texas Health Official Head Of HHS Center For Faith-Based Initiatives.
Foundation Gives Duke $2M For Brain Tumor Research.
Democrats Say Bush Budget Neglects NSF And NASA.
Seattle Times, The Hutch Duel Over Five-Part Series.
NCI Offers Bibliography On Risk Communication.
SEER Program Expansion Through Cost-Sharing.
Toxicology Program Seeks Comment On Substances.
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
- How City of Hope is turning microbiome science into better cancer care
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.”









